Red Dye #3: Understanding the FDA’s Decision
The FDA has pulled FD&C Red No. 3 from its list of approved food additives. This decision wasn’t driven by new research but came after a petition from food safety and environmental groups.
FDA
FDA Panel Backs New Alzheimer’s Drug
The FDA advisory panel has recommended the approval of donanemab, a new Alzheimer’s drug by Eli Lilly, after voting unanimously that it effectively slows early-stage Alzheimer’s disease and that its benefits outweigh the risks.